Related Experiment Video

Updated: May 13, 2026

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

Off label use of lithium in the treatment of Huntington's disease: A case series

Vijay Danivas1, Nagaraj S Moily, Rohini Thimmaiah

  • 1Department of Psychiatry, National Institute of Mental Health and Neuro Sciences, Bangalore, Karnataka, India.

Indian Journal of Psychiatry
|February 27, 2013
PubMed

Insights

Lithium may help manage Huntington's disease symptoms. This study found lithium prevented chorea progression and stabilized mood in three patients with this neurodegenerative disorder.

Area of Science:

  • Neuroscience
  • Genetics
  • Pharmacology

Background:

  • Huntington's disease is a progressive neurodegenerative disorder.
  • Characterized by chorea, psychiatric issues, and striatal atrophy.
  • Caused by CAG expansion in the Huntingtin gene.

Purpose of the Study:

  • To evaluate lithium's efficacy in treating Huntington's disease.
  • To assess lithium's impact on chorea and mood stabilization.

Main Methods:

  • Case series of three Huntington's disease patients.
  • Treatment with lithium.
  • Observation of clinical progression and mood stability.

Main Results:

  • Lithium administration prevented the progression of chorea.
  • Lithium treatment helped stabilize mood in patients.
  • Observed neuroprotective effects of lithium.

Conclusions:

  • Lithium shows potential as a therapeutic agent for Huntington's disease.
  • Further research is warranted to elucidate lithium's mechanism of action in Huntington's disease.
  • Lithium may offer a novel strategy for managing Huntington's disease symptoms.
Keywords:
Huntington's diseaselithiumneuroprotection

More Related Videos

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders08:33

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...